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Nitric oxide inhibits the formation of advanced glycation end Advanced glycation end products (AGEs) are ele-
products. vated in plasma and tissue proteins of uremic patients
Background. Advanced glycation end products (AGEs) are [1–3]. Their accumulation has been ascribed to the reten-
elevated in renal failure and have been implicated in the patho- tion of various carbonyl intermediates derived from car-genesis of several uremic complications. Their formation is
bohydrates and lipids (carbonyl stress) [4]. The levels ofclosely associated with oxidative stress. The recent observation
pentosidine, a well-studied AGE structure, are highly cor-that nitric oxide (NO) has an antioxidant effect led us to exam-
ine the possible role of NO in the generation of AGEs. related with those of precursor carbonyl compounds [5].
Methods. We examined the effect of NO donors, 2,29- Advanced glycation end products have been impli-
(hydroxynitrosohydrazono)bis-ethanamine (NOC18) and S- cated in the pathogenesis of vascular complications in
nitroso-N-acetyl-DL-penicillamine (SNAP), on the in vitro for- uremia, a major cause of morbidity and mortality. Levels
mation of pentosidine, which was used as a surrogate marker
of AGEs in arterial tissues are higher in dialysis patientsfor AGEs. Bovine serum albumin was incubated under air at
than in normal subjects [6]. Recent in vitro and in vivo378C in a medium containing either several AGE precursors
studies suggest that they play an active role in athero-or uremic plasma. To elucidate further the mechanism of the
NO effect on AGE formation, we examined the generation genesis. AGE-modified proteins initiate a range of
of free radicals and carbonyls in pentose-driven pentosidine inflammatory responses, including stimulation of mono-
formation. cyte chemotaxis [7, 8], secretion of inflammatory cyto-
Results. NO donors significantly inhibit the formation of kines from macrophages [8, 9], proliferation of vascular
pentosidine in a dose-dependent manner. The effect is abol-
smooth muscle cells [10], stimulation of aggregation ofished by the addition of a NO scavenging agent, 2-(4-carbo-
platelets [11], and stimulation of vascular endothelialxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide (car-
growth factor expression [12]. These biological activitiesboxy-PTIO). The inhibitory effect results from NO but not
from the NO donor molecule. It is best explained by the ability may account, at least in part, for the development of
of NO to scavenge carbon-centered radicals, hydroxyl radical, atherosclerosis. Furthermore, oral administration of the
and carbonyl compounds. inhibitor of carbonyl amine reaction 2-isopropylidenehy-
Conclusions. NO inhibits pentosidine formation by scaveng- drazono-4-oxo-thiazolidin-5-ylacetanilide (OPB-9195) to
ing free radicals and by inhibiting carbonyl compound forma-
rats after balloon injury of their carotid arteries effec-tion. NO might be implicated in the atherogenic and inflamma-
tively reduces neointima proliferation in arterial wallstory effects of AGEs: Reduced NO production and increased
[13].oxidative stress associated with atherosclerotic lesions may ac-
celerate AGE formation and, thus, exacerbate endothelial dys- The mechanism regulating AGE formation in vascular
function and accelerate the development of atherosclerosis in lesions is of particular interest. AGE formation is closely
uremia. related to oxidative stress (glycoxidation) [14]. There is
a significant correlation between the levels of AGEs and
antioxidant enzymes, such as glutathione peroxidase and
1 See Editorial by Devuyst and van Ypersele de Strihou, p. 1814 Cu/Zn-superoxide dismutase, in uremic plasma [15].
Nitric oxide (NO) and NO donors are known to inhibitKey words: anti-oxidant, chronic renal failure, pentosidine, uremia,
glycoxidation, NOC18, SNAP. lipid peroxidation in low-density lipoprotein [16, 17] by
directly scavenging peroxyl radicals [18]. They mightReceived for publication October 28, 1999
prove to be powerful anti-oxidants. We therefore evalu-and in revised form April 28, 2000
Accepted for publication May 10, 2000 ated the effect of NO on AGE formation.
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generation, used as a surrogate marker for AGEs, and Pentosidine measurement by high-performance
demonstrate that indeed two NO donors, 2,29-(hydroxy- liquid chromatography
nitrosohydrazono)bis-ethanamine (NOC18) and S-nitroso- Bovine serum albumin samples incubated with re-
N-acetyl-DL-penicillamine (SNAP), effectively inhibit agents (50 mL) were mixed with an equal volume of 10%
the formation of AGEs. This NO-mediated inhibition trichloroacetic acid and were centrifuged at 5000 3 g
of AGE formation appears mediated by the scavenging for five minutes. The supernatant was discarded, and the
of free radicals and carbonyl compounds. pellet was washed with 300 mL of 5% trichloroacetic
acid. The pellet was dried under vacuum, lyophilized,
and hydrolyzed by 100 mL of 6 N HCl for 16 hours atMETHODS
1108C with nitrogen. Plasma samples (50 mL) were di-In vitro incubation experiments
rectly hydrolyzed by 50 mL of 12 N HCl for 16 hours at
Sixty milligrams of essentially fatty acid-free grade 1108C with nitrogen. The acid hydrolysates were subse-
bovine serum albumin (BSA; Sigma, St. Louis, MO, quently neutralized with 100 mL of 5 N NaOH and 200 mL
USA) were incubated with air for three days at 378C in of 0.5 mol/L phosphate buffer (pH 7.4), filtered through
dark with either 10 mmol/L ribose, ascorbic acid, glucose, a 0.5 mm pore filter, and diluted with phosphate-buffered
or arabinose in 2.0 mL of 0.2 mol/L sodium phosphate saline.
buffer (pH 7.4). One and 10.0 mmol/L NOC18 (Dojindo The pentosidine content was analyzed in duplicate on
Laboratories, Kumamoto, Japan) and SNAP were used a reverse-phase high-performance liquid chromatogra-
as NO donors [19]. The half-lives of these NO donors phy (HPLC) according to our previous methods [3, 21].
were determined by monitoring the decay of their char- In brief, a 50 mL solution of acid hydrolysate diluted by
acteristic absorptions at 254 and 590 nm for NOC18 PBS was injected into an HPLC system and separated
and SNAP, respectively. Half-lives of NOC18 and SNAP on a C18 reverse-phase column (Waters, Tokyo, Japan).
under these conditions were 21 and 27 hours, respec- The effluent was monitored using a fluorescence detector
tively. They were thus expected to release NO continu- (RF-10A; Shimadzu, Kyoto, Japan) and an excitation-
ously during the three-day incubation. The oxygen ten-
emission wavelength of 335/385 nm. Synthetic pentosi-
sion in the reaction medium did not decrease significantly
dine was used as a standard [3]. The detection limit wasduring the procedure despite the consumption of O2 by 0.05 pmol of pentosidine per mg of proteins. All samplesNO donors (52.5 6 0.86 mm Hg at the initiation of
assayed in this study were analyzed in single batches toincubation and 51.3 6 1.29 mm Hg at the end). The
exclude interassay variation. Intra-assay coefficients ofeffect of degradation products of NOC18 and SNAP was
variation of the assays ranged from 5 to 12%.also examined to determine whether the observed effect
by NO donors depends on liberated NO. Degradation Measurement of free radicals and dicarbonyl
product of NOC18, diethylenetriamine, was purchased sugar formation
from Aldrich (Milwaukee, WI, USA). A degradation
The free radical formation associated with ribose au-product of SNAP was prepared by irradiating 100
toxidation was measured with spin-trapping technique.mmol/L SNAP in 0.2 mol/L sodium phosphate buffer
Twenty mmol/L of a-phenyl-tert-butylnitrone (PBN;(pH 7.4) with a 75 W xenon lamp for one hour at room
Wako, Tokyo, Japan) was added to 0.2 mol/L phosphatetemperature. The degradation was confirmed by the ab-
buffer containing 10 mmol/L ribose and/or 30 mg/mLsence of absorption above 400 nm. In some experiments,
BSA, which was incubated for three days at 378C underthe sample incubation was performed in the presence of
air. The resulting solution was sucked into a flat quartz2-(4-carboxyphenyl)-4,4,5,5,-tetramethyl-imidazoline-1-
cell (180 mL; JEOL, Tokyo, Japan), and the nitroxideoxyl 3-oxide (carboxy-PTIO), which is a NO-specific
radical was measured on an electron-spin resonancescavenging agent [20].
spectrometer (JES-FE2XG; JEOL) under the followingFresh heparinized predialysis plasma samples were ob-
conditions: microwave frequency, 9.42 GHz; magnetictained with informed consent from five nondiabetic he-
field, 334.5 6 5 mT; time constant, 0.3 seconds; micro-modialysis patients (3 males and 2 females, age range of
wave power 8 mW; field modulation width 0.2 mT; ampli-41 to 62 years old, hemodialysis duration range of 6 to 13
tude 1.6 3 1000; sweep time 2 min/10 mT. The amountyears). Hemodialysis was performed with a cuprophane
of nitroxide radical was determined as the relative signaldialyzer and dialysate containing 30 mmol/L of bicarbon-
height to the third signal of external instrumental stan-ate and 8 mmol/L of acetate. All plasma samples were
dard (Mn21 in MgO).pooled. Two milliliters of pooled plasma were incubated
Hydroxyl radical and dicarbonyl sugar formed duringwith air at 378C for seven days in the presence of 1.0
three-day incubation at 378C were measured in 0.2 mol/Land 10.0 mmol/L SNAP or its degradation product. The
phosphate buffer (pH 7.4) containing 10 mmol/L riboseexperiments were performed four times. The effect of
carboxy-PTIO was also examined. with or without NO donors and/or their degradation
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Fig. 1. Production of pentosidine (A) and di-
carbonyls (B) during the glycoxidation of ri-
bose, arabinose, and ascorbic acid (10 mmol/L
each). The reaction was conducted in the pres-
ence of BSA (30 mg/mL) for one or three
days at 378C. Symbols are: (s) ribose; (h)
arabinose; (d) ascorbic acid. Dicarbonyls were
measured by Girard T reagent with absorb-
ance at 295 nm. *P , 0.0001 vs. arabinose or
ascorbic acid.
products. Hydroxyl radical formation was estimated with we used only ribose as a source of pentosidine and dicar-
bonyls.the hydroxylation of 1 mmol/L sodium benzoate mea-
sured by fluorospectrometer (RF-1500; Shimadzu, Kyoto,
Inhibitory effect of NO on pentosidine formationJapan) with excitation at 308 nm and emission at 410 nm
[22]. The known amount of sodium salicylate (0.1 to 50.0 SNAP and its degradation product (10 mmol/L each)
were incubated with ribose (10 mmol/L) and BSA (30mmol/L) was used as an assay standard. Dicarbonyl sugar
was measured using Girard T reagent [23]. The assay mg/mL) at 378C for three days. SNAP decreased pentosi-
dine formation by 30.0%, whereas denatured SNAP hadwas performed at pH 2.9 as reported elsewhere [24],
and the reaction product between dicarbonyls and the no effect (Fig. 2). Carboxy-PTIO, a scavenger of NO,
effectively quenched the inhibitory effect of SNAP onreagent was measured by spectrophotometer (BioSpec-
1600; Shimadzu) with absorbance at 295 nm. pentosidine generation. Carboxy-PTIO per se did not
affect pentosidine generation during the incubation with
Statistical analysis BSA. The NO donor thus inhibits pentosidine formation
on BSA from ribose. This inhibitory effect derives fromData are expressed as means 6 SD. One-way analysis
of variance (ANOVA) was used for a statistical evalua- NO but not from the NO donor molecule or its degrada-
tion product.tion of significant difference between the groups.
Another NO donor, NOC18, was also highly inhibitory
on the pentosidine formation: In the presence of 10
RESULTS
mmol/L NOC18, the pentosidine generation was de-
Pentosidine and dicarbonyl formation creased by 58.5% on BSA incubated with 10 mmol/L
ribose at 378C for three days. However, diethylenetria-Ribose, ascorbic acid, and glucose (and its autoxida-
tion product arabinose) are efficient precursors for pen- mine, the degradation product of NOC18, is a potent
inhibitor for pentosidine formation as it has two primarytosidine through the formation of intermediate carbonyl
compounds [25–27]. The efficacy of these precursors on amino groups, which react with any carbonyls to form
Schiff base products. NOC18 was thus inappropriate topentosidine and dicarbonyl formations was examined in
incubation experiments with BSA. Pentosidine yields estimate the NO effect on pentosidine formation.
after three days with 10 mmol/L ribose, arabinose, or
Effect of NO on free radical formation duringascorbic acid averaged 697.3 6 34.1, 77.8 6 3.36, or
ribose glycoxidation16.9 6 3.19 pmol/mg albumin, respectively (Fig. 1A). By
contrast, the pentosidine yield with 10 mmol/L glucose Free radicals are formed during the glycoxidation reac-
tions [14, 28]. As NO acts as a free radical scavenger inwas below the detection limit. For dicarbonyls, the exper-
iments were performed without BSA for three days at lipid peroxidation [18], its inhibitory effect on pentosi-
dine formation might result from its ability to scavenge378C. As shown in Figure 1B, ribose produced approxi-
mately 7.15 or 8.39 times more dicarbonyls than ascorbic free radicals generated during the glycoxidation. To test
this hypothesis, free radical formation during the oxida-acid or arabinose (2.317 6 0.116 vs. 0.324 6 0.001 or
0.276 6 0.008 arbitrary unit, respectively). Subsequently, tion of ribose in the presence or absence of BSA was
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Fig. 2. Effect of SNAP on pentosidine formation during three-day
incubation of BSA with 10 mmol/L ribose at 378C. The effect of dena-
tured SNAP (D-SNAP) and carboxy PTIO (C-PTIO) were also exam-
ined. *P , 0.0001 vs. ribose 1 BSA.
measured by PBN spin adduct formation with electron Fig. 3. Electron paramagnetic resonance (EPR) spectra for a-phenyl-
paramagnetic resonance (EPR). In this experiment, we tert-butylnitrone (PBN)-radical adduct generated by incubation of BSA
with ribose. The signals designated with an arrow are due to Mn21 inhad to use NOC18 because SNAP itself generates sulfur-
MgO used as an internal standard for signal intensity and field. (A)centered radicals (S-radical), which interfere with the PBN 1 ribose 1 BSA. (B) PBN 1 ribose 1 BSA 1 diethylenetriamine.
free radical detection. Although several radical species (C) PBN 1 ribose 1 BSA 1 NOC18. (D) PBN.
are formed in this system, including carbon-centered rad-
icals (C-radical) and oxygen-centered radical (O-radi-
cal), such as hydroxyl radical, superoxide, and alchoxyl product of NOC18, even though it decreased pentosidine
radicals via ribose autoxidation, only C-radicals are de- formation. The reactions behind this increase can be
tectable because PBN spin adducts of O-radicals are explained by equations 1 to 3. A short-lived O-radical
short lived and cannot be detected in this time span. (R-Ox) such as hydroxyl radical first forms during glycox-
Figure 3 shows typical EPR spectra obtained by the idation (equation 1). R-Ox is trapped by PBN (equation
reaction of ribose, BSA, and PBN. The spectra observed 2a) to form PBN-O-R adduct or to abstract hydrogen
in Figure 3 A and C have a g value of 2.0057 and hyper- from diethylenetriamine (DT), and resulting C-radicals
fine splittings of an 5 1.58 mT and ah 5 0.31 mT, which (DTx; equation 2b), which, in turn, are trapped by PBN
indicates a typical PBN spin adduct of C-radicals [29]. (equation 3):
The fact that the signal peak height did not change for
Autoxidationat least six hours further confirms that these signals are
due to C-radicals. The spectrum obtained from three Ribose ! R-Ox 1 Other product (Eq. 1)
days of incubation with PBN only did not show signifi-
R-Ox 1 PBN ! PBN-O-R (Eq. 2a)cant signals (Fig. 3D).
Figure 4 summarizes the relative peak height of the R-Ox 1 DT ! R-OH 1 DTx (Eq. 2b)
EPR signals attributed to PBN spin adducts of C-radi-
DTx 1 PBN ! PBN-DT (Eq. 3)cals. Note that the C-radical yield increased threefold
in the presence of diethylenetriamine, the degradation PBN-O-R is invisible because the adduct is short lived
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(10 mmol/L) in 0.2 mol/L PB was incubated with or
without NO donors and/or their degradation products
at 378C for three days. Ribose produces high levels of
hydroxybenzoate, a product of the reaction between ben-
zoate and hydroxyl radical (Fig. 5A). Hydroxyl radicals
are so reactive that any molecule can be an effective
scavenger. Diethylenetriamine and denatured SNAP ef-
fectively inhibit hydroxybenzoate formation. NOC18
suppresses the formation more than DT and SNAP com-
pletely abolishes hydroxybenzoate formation, an effect
absent with denatured SNAP, indicating that NO scav-
enges residual free hydroxyl radical. Figure 5B shows
the effects of SNAP on dicarbonyl formation. SNAP
completely suppresses dicarbonyl formation. The effect
of NOC18 on dicarbonyl formation was not estimated
because NOC18 and DT directly react with carbonyls,
as mentioned previously in this article.
Effect of NO on pentosidine formation in
uremic plasma
To test the inhibitory effect of NO on pentosidine
Fig. 4. Effect of NOC18 and its degradation product, diethylenetria-
formation under physiological conditions, plasma ob-mine (DT), on relative radical yield by incubation of BSA with ribose.
*P , 0.001. tained from uremic patients was incubated under air at
378C for three to seven days in the presence or absence
of SNAP. The pooled plasma from five uremic patients
has a higher basal level of pentosidine residues on pro-and cannot accumulate. DT therefore works as a con-
teins. Incubation increases pentosidine generation fromverter of invisible O-radical to visible C-radical. In the
accumulated pentosidine precursor carbonyl compoundspresence of NOC18, the C-radical yield decreased com-
(Fig. 6). The addition of SNAP significantly inhibits pen-pared with that with DT. Because NOC18 works as DT
tosidine formation in plasma samples in a dose-depen-plus 2 NO molecules attached to one of nitrogens of DT,
dent manner. Ten millimolar SNAP inhibits pentosidinethe effect of NO generated by NOC18 on free radical
formation by 25.1 and 27.6% after three and seven daysgeneration should be compared with that of DT rather
of incubation, respectively. Denatured SNAP has no in-than with that of ribose alone or ribose plus BSA. It
hibitory effect on pentosidine formation. Carboxy-PTIOmay be concluded that NO scavenges C-radicals. As
abolishes the inhibitory effect of SNAP. These findingsreported by previous authors [16–18], the most plausible
indicate that NO inhibits the pentosidine formation inmechanism of the NO-induced decrease in C-radicals is
uremic plasma.the quenching by NO of both R-Ox and DTx, as NO can
couple with any free radical by radical-radical reaction
generated in this glycoxidation (equations 5 and 6): DISCUSSION
We demonstrate that NO inhibits the formation ofR-Ox 1 xNO ! R-O-NO (Eq. 5)
pentosidine, a surrogate marker for AGEs. This inhibi-
DTx 1 xNO ! DT-NO (Eq. 6) tory effect is abolished by the NO scavenger carboxy-
PTIO. Further experiments with denatured product ofIncreased production of C-radicals by DT was also com-
NO donors demonstrate that the inhibitory effect of NOpletely suppressed by NOC18 in the absence of BSA.
donors is indeed attributable to NO itself and not to aThe radical yield was lower in the absence than in the
NO donor molecule or its degradation product.presence of BSA because BSA may be also attacked by
We have further examined the effects of NO donorsO-radicals and produce fragmented C-radicals [22]. Free
on the formation of unidentified free radicals by the PBNradicals are thus produced during ribose glycoxidation,
spin-trapping method, on hydroxyl radicals by hydroxy-and NO can scavenge these free radicals.
benzoate formation and on dicarbonyls by Girard-T re-
Effect of NO on hydroxyl radical and action in order to elucidate the mechanism by which NO
dicarbonyl formation inhibits pentosidine formation (Fig. 7). During autoxida-
tion of reducing sugars to dicarbonyls, dissolved oxygenWe next examined the effects of NO donors on the
formation of hydroxyl radicals and dicarbonyls. Ribose receives an electron to form superoxide, the source of
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Fig. 5. Effects of NO donors on the yield of
hydroxyl radical and dicarbonyls during ribose
glycoxidation. (A) Hydroxybenzoate forma-
tion associated with the generation of hy-
droxyl radical, measured by the fluorescence
(excitation at 308 nm and emission at 410 nm).
The concentration of hydroxybenzoate was
assayed as that of salicylate by comparing flu-
orescence intensity with the standard curve
made with salicylate. (B) Dicarbonyls mea-
sured with Girard T reagent (absorbance at
295 nm). DT, diethylenetriamine; D-SNAP,
denatured SNAP. *P , 0.0001 vs. ribose; †P ,
0.0001 vs. ribose 1 NOC18; §P , 0.0001 vs.
ribose 1 D-SNAP.
end, it is this reduction of dicarbonyl levels that results
in a diminished pentosidine formation. NO couples with
any free radical generated by autoxidation and breaks
the chain reactions that they are able to promote.
Our observations cast a new light on the intricate rela-
tionships between AGEs and NO and their ability to
generate pathological consequences. In arterial tissues,
AGE levels are higher in hemodialysis patients than in
normal subjects [5]. On immunohistochemical examina-
tion, AGEs, such as pentosidine and N e -(carboxymethyl)
lysine, are present in the fatty streak and thickened neo-
intima of arterial walls of uremic patients [12]. The stain-
ing pattern of AGEs corresponds with that of protein
carbonyls, a biomarker of oxidative protein damage [30].
In atherosclerosis, protein expression of endothelial NO
synthase (eNOS), which is responsible for NO synthesis
in endothelial cells and NO release, is markedly reduced
[31]. Reduced NO production together with increased
oxidative stress in atherosclerotic lesions [32] might
therefore accelerate the local formation of AGEs, endo-
thelial dysfunction, and thus the progression of athero-
sclerosis. Interestingly, NO release and expression of
eNOS protein are markedly reduced after exposure of
cultured endothelial cells to AGE-modified proteins
[33]. NO production and AGE formation appear there-
fore inextricably linked in atherosclerotic lesions.Fig. 6. Effect of SNAP on pentosidine formation by incubation of
In circulating plasma, the AGE contents of plasmaplasma of uremic patients at 378C. Symbols are: (h) pentosidine level
before incubation; ( ) three days of incubation; (j) seven days of proteins are also significantly higher in uremic than in
incubation. *P , 0.01 vs. HD plasma (3 days incubation); **P , 0.001 control subjects [3, 5]. Interestingly, some researchersvs. HD plasma (7 days incubation); †P , 0.0001 vs. HD plasma (7 days
reported that the plasma levels of NO and its metabolitesincubation).
are significantly lower in uremic than in control subjects
[34–36]. This is partially ascribed to the presence of inhib-hydroxyl radicals. Hydroxyl radicals can abstract hydro-
itor of NO synthase, NG, NG-dimethylarginine in uremicgen from any molecule to promote the oxidation of sug-
plasma [37] and to reduced arginine (substrate) availabil-ars and form of C-centered and O-centered free radicals.
ity [35]. To what extent the reduction of plasma NONO acts as a scavenger of all free radicals and conse-
quently suppresses dicarbonyl formation. At the very contributes to increased carbonyl stress and AGE forma-
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Fig. 7. Proposed mechanism for the inhibi-
tion of the pentosidine formation by NO. Re-
ducing sugars are autoxidized to their dicarbo-
nyls and reduce molecular oxygen to form
superoxide/hydroxyl radicals. These radicals
promote the chain reaction of sugar oxidation.
NO traps these radicals and sugar radicals to
inhibit whole sugar-autoxidation process. Con-
sequently, NO suppresses dicarbonyl and pen-
tosidine formation.
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